ICCB280
ICCB280 was capable of inducing differentiation and apoptosis of ATRA-resistant patient blasts strongly signify that the activity of this compound can overcome resistance to other current therapies for AML with an unfavorable prognosis.
Product Specifications
CAS Number
2041072-41-5
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
386.4
Molecular Formula
C23H18N2O4
Notes
Research use only, not for human use.
Receptor
C/EBPα
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
126452 100 µg
ESAM (Endothelial Cell-selective Adhesion Molecule, UNQ220/PRO246, W117m)
Sign In for Pricing
View Details 
PC108634 50 mg
(2- (1- (3,5-Bis (Trifluoromethyl) Benzyl) -5- (Pyridin-4-Yl) -1H-1,2,3-Triazol-4-Yl) Pyridin-3-Yl) (2-Chlorophenyl) Methanone
Sign In for Pricing
View Details MBS8120734-02 5x 0.1 mg
SETD7 Protein, Human, Recombinant (His Tag)
Sign In for Pricing
View Details 